FDC has informed that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in compliance with Code of Conduct of the Company to Regulate, Monitor and Report Trading by Designated Persons, the Trading Window for dealing in Securities of the company for all the Designated Persons, Connected Persons and their Immediate Relative(s), shall remain closed from Monday, July 01, 2024 until 48 hours after the declaration of the Unaudited Financial Results of the Company for the Quarter ended June 30, 2024. Accordingly, Designated Persons, Connected Persons and their Immediate Relative(s), are advised not to trade (buy or sell etc.) in the securities of the Company during the aforesaid period of closure of the Trading Window. The date of Board Meeting of the Company for consideration and approval of the Unaudited Financial Results for the Quarter ending on June 30, 2024 will be intimated in due course.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: